CFB
RMD icon

Cullen/Frost Bankers’s ResMed RMD Stock Holding History

Cullen/Frost Bankers’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3K Sell
89
-1,491
-94% -$309K ﹤0.01% 1080
2026
Q1 		$355K Buy
1,580
+39
+3% +$9.72K ﹤0.01% 472
2025
Q4 		$371K Buy
1,541
+1,003
+186% +$257K ﹤0.01% 467
2025
Q3 		$147K Sell
538
-37
-6% -$10.1K ﹤0.01% 585
2025
Q2 		$148K Buy
575
+147
+34% +$35.1K ﹤0.01% 570
2025
Q1 		$95.8K Hold
428
– – ﹤0.01% 615
2024
Q4 		$97.9K Buy
+428
New +$103K ﹤0.01% 604
2024
Q3 		– Sell
-535
Closed -$102K – 1352
2024
Q2 		$102K Sell
535
-463
-46% -$93.9K ﹤0.01% 585
2024
Q1 		$198K Hold
998
– – ﹤0.01% 483
2023
Q4 		$172K Hold
998
– – ﹤0.01% 502
2023
Q3 		$148K Sell
998
-800
-44% -$145K ﹤0.01% 549
2023
Q2 		$393K Sell
1,798
-6
-0.3% -$1.34K 0.01% 416
2023
Q1 		$395K Hold
1,804
– – 0.01% 416
2022
Q4 		$375K Hold
1,804
– – 0.01% 421
2022
Q3 		$394K Buy
1,804
+6
+0.3% +$1.37K 0.01% 415
2022
Q2 		$377K Hold
1,798
– – 0.01% 415
2022
Q1 		$436K Hold
1,798
– – 0.01% 419
2021
Q4 		$468K Hold
1,798
– – 0.01% 412
2021
Q3 		$474K Hold
1,798
– – 0.01% 398
2021
Q2 		$443K Hold
1,798
– – 0.01% 418
2021
Q1 		$349K Buy
1,798
+712
+66% +$143K 0.01% 441
2020
Q4 		$231K Sell
1,086
-3
-0.3% -$598 0.01% 474
2020
Q3 		$187K Buy
1,089
+1,086
+36,200% +$201K ﹤0.01% 483
2020
Q2 		$1K Buy
+3
New +$491 ﹤0.01% 1073
2020
Q1 		– Sell
-93
Closed -$14K – 1006
2019
Q4 		$14K Hold
93
– – ﹤0.01% 856
2019
Q3 		$13K Hold
93
– – ﹤0.01% 797
2019
Q2 		$11K Sell
93
-34
-27% -$3.77K ﹤0.01% 826
2019
Q1 		$13K Buy
+127
New +$13.1K ﹤0.01% 725

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cullen/Frost Bankers's RMD Position: Q2 2026 in Review

Cullen/Frost Bankers reduced its ResMed (RMD) stake by 94% in Q2 2026, selling an estimated $309K and leaving 89 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

Cullen/Frost Bankers first reported a position in RMD in Q1 2019 and has held it in 28 quarters since. The position peaked at $474K in Q3 2021. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Cullen/Frost Bankers held 89 shares of ResMed worth $17.3K as of Q2 2026.
  • Cullen/Frost Bankers sold 1,491 ResMed shares in Q2 2026, an estimated $309K.
  • ResMed made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #1080 holding.
  • Cullen/Frost Bankers first reported a position in ResMed in Q1 2019 and has held it in 28 quarters since.
  • Cullen/Frost Bankers's ResMed position peaked at $474K in Q3 2021.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.